JNJ
Johnson & Johnson
NYSE: JNJ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$229.85
+1.10% today
Updated 2026-04-29
Market cap
$547.28B
P/E ratio
26.31
P/S ratio
5.68x
EPS (TTM)
$8.64
Dividend yield
2.28%
52W range
$142 – $252
Volume
8.0M
Johnson & Johnson (JNJ) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+1.4%
Last 4 quarters
Revenue YoY growth
+9.9%
Most recent quarter
EPS YoY growth
-2.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.1%
Last 8 reports
Positive reaction rate
75%
6 of 8 quarters
Largest single-day move
+5.0%
2025-07-16
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-14 | $2.70 | +0.7% | $237.96 | $238.67 | +0.3% |
| 2026-01-21 | $2.46 | +0.0% | $217.06 | $217.34 | +0.1% |
| 2025-10-14 | $2.80 | +1.4% | $188.71 | $188.98 | +0.1% |
| 2025-07-16 | $2.77 | +3.4% | $152.27 | $159.93 | +5.0% |
| 2025-04-15 | $2.77 | +7.4% | $150.20 | $149.76 | -0.3% |
| 2025-01-22 | $2.04 | +1.5% | $143.01 | $141.56 | -1.0% |
| 2024-10-15 | $2.42 | +9.5% | $154.75 | $157.32 | +1.7% |
| 2024-07-17 | $2.82 | +4.4% | $143.52 | $147.71 | +2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $2.68 | $2.70 | +0.7% | $24.06B | +9.9% |
| 2025-12-31 | $2.46 | $2.46 | +0.0% | $24.56B | +9.1% |
| 2025-09-30 | $2.76 | $2.80 | +1.4% | $23.99B | +6.8% |
| 2025-06-30 | $2.68 | $2.77 | +3.4% | $23.74B | +5.8% |
| 2025-03-31 | $2.58 | $2.77 | +7.4% | $21.89B | +2.4% |
| 2024-12-31 | $2.01 | $2.04 | +1.5% | $22.52B | +5.3% |
| 2024-09-30 | $2.21 | $2.42 | +9.5% | $22.47B | +5.2% |
| 2024-06-30 | $2.70 | $2.82 | +4.4% | $22.45B | — |
| 2024-03-31 | $2.65 | $2.71 | +2.3% | $21.38B | — |
| 2023-12-31 | $2.28 | $2.29 | +0.4% | $21.39B | — |
| 2023-09-30 | $2.52 | $2.66 | +5.6% | $21.35B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $11.80 | $102.3B | +8.6% | 20 | high |
| 2027 (E) | $12.65 | $109.9B | +7.4% | 20 | high |
| 2028 (E) | $13.45 | $117.2B | +6.6% | 20 | medium |
| 2029 (E) | $14.20 | $124.1B | +5.9% | 20 | medium |
| 2030 (E) | $14.85 | $130.5B | +5.1% | 20 | medium |
Frequently asked questions
Has Johnson & Johnson beaten earnings estimates?
Johnson & Johnson has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +1.4% over the last 4 quarters.
How does JNJ stock react to earnings?
JNJ stock has moved an average of +1.1% in the trading day following earnings over its last 8 reports, with positive reactions in 75% of those quarters.
What is Johnson & Johnson's revenue growth rate?
Johnson & Johnson reported year-over-year revenue growth of +9.9% in its most recent quarter, with EPS growing -2.5% year-over-year.
What is the expected EPS for JNJ in 2026?
Analysts expect Johnson & Johnson to report EPS of $11.80 for fiscal year 2026, on revenue of $102.3B, based on estimates from 20 analysts.